EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
-0.12%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$206M
AUM Growth
+$206M
(-33%)
Cap. Flow
-$95.6M
Cap. Flow
% of AUM
-46.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
16
New
2
Increased
1
Reduced
4
Closed
6
Top Buys
| 1 |
Tenaya Therapeutics
TNYA
|
$18.9M |
| 2 |
Surrozen
SRZN
|
$5.69M |
| 3 |
Pinduoduo
PDD
|
$223K |
Top Sells
| 1 |
PMV Pharmaceuticals
PMVP
|
$33.9M |
| 2 |
Denali Therapeutics
DNLI
|
$25.4M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$18.7M |
| 4 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$13.9M |
| 5 |
Snowflake
SNOW
|
$11.4M |
Sector Composition
| 1 | Healthcare | 97.48% |
| 2 | Financials | 1.97% |
| 3 | Consumer Discretionary | 0.54% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PMV Pharmaceuticals
PMVP
$74.2M
| $82.5M | 40.12% |
2,769,813
-1,138,864
| -29% | -$33.9M |
|
2
Alector
ALEC
$238M
| $22.4M | 10.88% |
980,894
| – | – |
|
3
RAPT Therapeutics
RAPT
$188M
| $19.7M | 9.59% |
635,177
-100,624
| -14% | -$3.12M |
|
|
4
Tenaya Therapeutics
TNYA
$184M
| $18.9M | 9.19% |
+915,705
| New | +$18.9M |
|
5
Foghorn Therapeutics
FHTX
$286M
| $17.6M | 8.54% |
1,261,261
| – | – |
|
|
NGM
6
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $17.5M | 8.5% |
832,274
-661,075
| -44% | -$13.9M |
|
7
Oric Pharmaceuticals
ORIC
$994M
| $16.3M | 7.9% |
777,193
-219,541
| -22% | -$4.59M |
|
|
8
Surrozen
SRZN
$104M
| $5.69M | 2.76% |
+802,965
| New | +$5.69M |
|
9
First Financial Bancorp
FFBC
$2.51B
| $4.06M | 1.97% |
173,576
| – | – |
|
|
10
Pinduoduo
PDD
$171B
| $1.11M | 0.54% |
12,262
+2,456
| +25% | +$223K |
|
11
Beam Therapeutics
BEAM
$1.66B
| – | – |
-31,131
| Closed | -$4.01M |
|
|
12
Denali Therapeutics
DNLI
$2.23B
| – | – |
-323,749
| Closed | -$25.4M |
|
13
Nurix Therapeutics
NRIX
$714M
| – | – |
-154,426
| Closed | -$4.1M |
|
|
14
Snowflake
SNOW
$79.6B
| – | – |
-47,136
| Closed | -$11.4M |
|
15
Vir Biotechnology
VIR
$686M
| – | – |
-25,866
| Closed | -$1.22M |
|
|
CNST
16
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – |
-554,325
| Closed | -$18.7M |
|